Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 1A Y-linked (EIF1AY) is a protein-coding gene located on the non-recombining region of the Y chromosome. EIF1AY encodes a Y-chromosome–specific isoform of the highly conserved eukaryotic translation initiation factor 1A, which is essential for the initiation of protein synthesis by aiding in the binding of the initiator methionine-tRNA to the 40S ribosomal subunit and scanning for the start codon. The protein is a component of the 43S pre-initiation complex, facilitates scanning and start codon recognition, and promotes assembly of the 80S ribosome at the initiation codon. EIF1AY is predominantly expressed in the testis and is considered critical for normal spermatogenesis. Loss or decreased expression of EIF1AY has been implicated in male infertility, particularly non-obstructive azoospermia and spermatogenic maturation arrest. There are no known therapeutic drugs directly targeting EIF1AY, and its primary role is in normal cell physiology rather than as a pharmacologic target[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 1A Y-linked (EIF1AY).